AAPL   376.30 (+0.66%)
MSFT   212.03 (+0.63%)
GOOGL   1,513.83 (+0.95%)
AMZN   3,043.84 (-0.43%)
NVDA   398.66 (+1.29%)
BABA   237.89 (-0.88%)
MU   49.94 (-1.92%)
GE   6.79 (-3.00%)
TSLA   1,386.00 (+1.05%)
AMD   53.33 (-0.13%)
T   30.36 (-0.43%)
ACB   12.27 (+0.74%)
DIS   113.42 (-0.87%)
NFLX   494.21 (+0.08%)
AAPL   376.30 (+0.66%)
MSFT   212.03 (+0.63%)
GOOGL   1,513.83 (+0.95%)
AMZN   3,043.84 (-0.43%)
NVDA   398.66 (+1.29%)
BABA   237.89 (-0.88%)
MU   49.94 (-1.92%)
GE   6.79 (-3.00%)
TSLA   1,386.00 (+1.05%)
AMD   53.33 (-0.13%)
T   30.36 (-0.43%)
ACB   12.27 (+0.74%)
DIS   113.42 (-0.87%)
NFLX   494.21 (+0.08%)
AAPL   376.30 (+0.66%)
MSFT   212.03 (+0.63%)
GOOGL   1,513.83 (+0.95%)
AMZN   3,043.84 (-0.43%)
NVDA   398.66 (+1.29%)
BABA   237.89 (-0.88%)
MU   49.94 (-1.92%)
GE   6.79 (-3.00%)
TSLA   1,386.00 (+1.05%)
AMD   53.33 (-0.13%)
T   30.36 (-0.43%)
ACB   12.27 (+0.74%)
DIS   113.42 (-0.87%)
NFLX   494.21 (+0.08%)
AAPL   376.30 (+0.66%)
MSFT   212.03 (+0.63%)
GOOGL   1,513.83 (+0.95%)
AMZN   3,043.84 (-0.43%)
NVDA   398.66 (+1.29%)
BABA   237.89 (-0.88%)
MU   49.94 (-1.92%)
GE   6.79 (-3.00%)
TSLA   1,386.00 (+1.05%)
AMD   53.33 (-0.13%)
T   30.36 (-0.43%)
ACB   12.27 (+0.74%)
DIS   113.42 (-0.87%)
NFLX   494.21 (+0.08%)
Log in

NYSEAMERICAN:ELMDElectromed Stock Price, Forecast & News

$16.06
+0.49 (+3.15 %)
(As of 07/7/2020 12:23 PM ET)
Add
Compare
Today's Range
$15.46
Now: $16.06
$16.43
50-Day Range N/A
52-Week Range
$5.17
Now: $16.06
$19.73
Volume104,712 shs
Average Volume149,239 shs
Market Capitalization$136.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Read More
Electromed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.76 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:ELMD
Previous SymbolNYSEMKT:ELMD
CUSIPN/A
Phone+1-952-7589299

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees132
Market Cap$136.25 million
Next Earnings Date8/25/2020 (Estimated)
OptionableNot Optionable

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Electromed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Electromed.

When is Electromed's next earnings date?

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Electromed.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) released its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.01. The medical equipment provider had revenue of $8.74 million for the quarter. View Electromed's earnings history.

What price target have analysts set for ELMD?

1 analysts have issued 12-month price objectives for Electromed's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Electromed's stock price to reach $12.00 in the next year. This suggests that the stock has a possible downside of 25.3%. View analysts' price targets for Electromed.

Has Electromed been receiving favorable news coverage?

News stories about ELMD stock have been trending negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Electromed earned a news impact score of -2.1 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Electromed.

Are investors shorting Electromed?

Electromed saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 150,700 shares, an increase of 80.0% from the June 15th total of 83,700 shares. Based on an average daily volume of 190,000 shares, the days-to-cover ratio is currently 0.8 days. Currently, 2.3% of the shares of the company are short sold. View Electromed's Current Options Chain.

Who are some of Electromed's key competitors?

What other stocks do shareholders of Electromed own?

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)
  • Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George J.D., Sec. (Age 70)
  • Ms. Kathryn Thompson, VP of Reimbursement

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $16.06.

How big of a company is Electromed?

Electromed has a market capitalization of $136.25 million. Electromed employs 132 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.